Description

Imat 400 mg Tablet is an oral targeted antineoplastic (anti-cancer) medication manufactured by Zydus Lifesciences (Zydus Cadila). It is primarily prescribed as a first-line treatment for Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL), which are specific types of blood and bone marrow cancers. Additionally, it is used to manage Gastrointestinal Stromal Tumors (GIST)—tumors that develop within the walls of the stomach or digestive tract.